» Articles » PMID: 18691894

The Efficacy and Selectivity of Tumor Cell Killing by Akt Inhibitors Are Substantially Increased by Chloroquine

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2008 Aug 12
PMID 18691894
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

This study was to evaluate the enhancement value of chloroquine (CQ) in cancer cell killing when used in combination with Akt inhibitors. The results showed that the combination of CQ and Akt inhibitors is much more effective than either one alone. Importantly, the CQ-mediated chemosensitization of cell killing effects by Akt inhibitors is cancer specific. In particular, when combined with 10 microM CQ, 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one (an Akt1 and 2 inhibitor; compound 8) killed cancer cells 10-120 times more effectively than normal cells. Thus, CQ is a very effective and cancer-specific chemosensitizer when used in combination with Akt inhibitors.

Citing Articles

The role of chaperone-mediated autophagy in drug resistance.

Teixeira A, Ramalho M, de Souza I, Andrade I, Osawa I, Guedes C Genet Mol Biol. 2024; 47(Suppl 1):e20230317.

PMID: 38829285 PMC: 11145944. DOI: 10.1590/1678-4685-GMB-2023-0317.


A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors.

Karim N, Ullah A, Ahmad I, Bahassi E, Olowokure O, Khaled A Front Oncol. 2022; 12:811411.

PMID: 35574311 PMC: 9102974. DOI: 10.3389/fonc.2022.811411.


Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review.

Mohsen S, Sobash P, Algwaiz G, Nasef N, Al-Zeidaneen S, Karim N Curr Oncol. 2022; 29(3):1695-1708.

PMID: 35323341 PMC: 8946974. DOI: 10.3390/curroncol29030141.


Aminoquinolines as Translational Models for Drug Repurposing: Anticancer Adjuvant Properties and Toxicokinetic-Related Features.

Ferreira P, Ferreira J, de Sousa R, Bezerra D, Militao G J Oncol. 2021; 2021:3569349.

PMID: 34527050 PMC: 8437624. DOI: 10.1155/2021/3569349.


Examination of novel 4-aminoquinoline derivatives designed and synthesized by a hybrid pharmacophore approach to enhance their anticancer activities.

Solomon V, Pundir S, Lee H Sci Rep. 2019; 9(1):6315.

PMID: 31004122 PMC: 6474902. DOI: 10.1038/s41598-019-42816-4.